Company news
Anagenics Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Midkine alopecia patent European allowance
February 6, 2017
Cellmids usa midkine patent for alopecia allowed
January 30, 2017
Appendix 4C
January 23, 2017
Cellmid receives australian govt grant for midkine programme
January 18, 2017
Cellmid Updates on CxBladder License
December 12, 2016
Cellmid receives 831K R&D tax credit
November 29, 2016
USA launch of evolis
November 2, 2016
Cellmid: Appendix 3Y- Change of Director’s Interest Notice
November 1, 2016
ASX Market Release - Reinstatement
October 31, 2016
Cellmid records highest ever quarterly sales for evolis
October 10, 2016
Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer
October 5, 2016
European Midkine Patent For Surgical Adhesion Allowed
September 22, 2016
New Publication for Cellmids Midkine Antibody
August 9, 2016
Transcript of Cellmid Investor Briefing Call
July 29, 2016
CDY: Ikon Legal Action
July 22, 2016
USA Distribution Partnership for Cellmids Evolis
July 19, 2016
MK antibody publication and patent in bone healing
June 24, 2016
Midkine Strategy Update
April 8, 2016
Response to ASX Query
March 30, 2016
Cellmid to Refinance RnD Loan
February 26, 2016
Cellmid receives $1.12M R&D Tax Credit
February 11, 2016
Key Antibody Patent Granted in Europe
February 10, 2016
Decks
The 5 newest of 24 decks. Every deck is listed under its year.
- H1 2026 Earnings Presentation
Earnings · 12 slides · Feb 25, 2026
- Shareholder Meeting (November 2025)
Shareholder meeting · 14 slides · Nov 25, 2025
- FY2025 Earnings Presentation
Earnings · 15 slides · Aug 28, 2025
- Q3 2025 Earnings Presentation
Earnings · 15 slides · May 5, 2025
- Shareholder Meeting (November 2024)
Shareholder meeting · 12 slides · Nov 26, 2024